Shanker Nesathurai

Dr. Shanker Nesathurai


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Sensors
Verified
Journal Article
Open access
PDF file
Farah MasoodFarah Masood
Farah Masood
MSMilan Sharma
Milan Sharma
DMDavleen Mand
Davleen Mand
SNShanker Nesathurai
Shanker Nesathurai
HSHeather A. Simmons
Heather A. Simmons
HAHussein A. Abdullah
Hussein A. Abdullah
In this study, a traumatic spinal cord injury (TSCI) classification system is proposed using a convolutional neural network (CNN) technique with automatically learned features from electromyography (EMG) signals for a non-human primate (NHP) model. A comparison between the proposed classification system and a classical classification method (k-nearest neighbors, kNN) is also presented. Developing such an NHP model with a suitable assessment tool (i.e., classifier) is a crucial step in detecting the effect of TSCI using EMG, which is expected to be essential in the evaluation of the efficacy of new TSCI treatments. Intramuscular EMG data were collected from an agonist/antagonist tail muscle pair for the pre- and post-spinal cord lesion from five Macaca fasicularis monkeys. The proposed classifier is based on a CNN using filtered segmented EMG signals from the pre- and post-lesion periods as inputs, while the kNN is designed using four hand-crafted EMG features. The results suggest that the CNN provides a promising classification technique for TSCI, compared to conventional machine learning classification. The kNN with hand-crafted EMG features classified the pre- and post-lesion EMG data with an F-measure of 89.7% and 92.7% for the left- and right-side muscles, respectively, while the CNN with the EMG segments classified the data with an F-measure of 89.8% and 96.9% for the left- and right-side muscles, respectively. Finally, the proposed deep learning classification model (CNN), with its learning ability of high-level features using EMG segments as inputs, shows high potential and promising results for use as a TSCI classification system. Future studies can confirm this finding by considering more subjects.

27 July 2019 in Sensors
Verified
Journal Article
Open access
PDF file
Farah MasoodFarah Masood
Farah Masood
HAHussein A. Abdullah
Hussein A. Abdullah
NSNitin Seth
Nitin Seth
HSHeather Simmons
Heather Simmons
KBKevin Brunner
Kevin Brunner
SNShanker Nesathurai
Shanker Nesathurai
This study aims to characterize traumatic spinal cord injury (TSCI) neurophysiologically using an intramuscular fine-wire electromyography (EMG) electrode pair. EMG data were collected from an agonist-antagonist pair of tail muscles of Macaca fasicularis, pre- and post-lesion, and for a treatment and control group. The EMG signals were decomposed into multi-resolution subsets using wavelet transforms (WT), then the relative power (RP) was calculated for each individual reconstructed EMG sub-band. Linear mixed models were developed to test three hypotheses: (i) asymmetrical volitional activity of left and right side tail muscles (ii) the effect of the experimental TSCI on the frequency content of the EMG signal, (iii) and the effect of an experimental treatment. The results from the electrode pair data suggested that there is asymmetry in the EMG response of the left and right side muscles (p-value < 0.001). This is consistent with the construct of limb dominance. The results also suggest that the lesion resulted in clear changes in the EMG frequency distribution in the post-lesion period with a significant increment in the low-frequency sub-bands (D4, D6, and A6) of the left and right side, also a significant reduction in the high-frequency sub-bands (D1 and D2) of the right side (p-value < 0.001). The preliminary results suggest that using the RP of the EMG data, the fine-wire intramuscular EMG electrode pair are a suitable method of monitoring and measuring treatment effects of experimental treatments for spinal cord injury (SCI).

1 February 2018
Verified
Journal Article
Closed access
NSNitin Seth
Nitin Seth
HSHeather A. Simmons
Heather A. Simmons
Farah MasoodFarah Masood
Farah Masood
WGWilliam A. Graham
William A. Graham
DRDouglas L. Rosene
Douglas L. Rosene
SNShanker Nesathurai
Shanker Nesathurai

4 January 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PSPaul Stacey
Paul Stacey
AMArun Mensinkai
Arun Mensinkai
PBPankaj Bansal
Pankaj Bansal
SHSeyed-Hossein Hosseini
Seyed-Hossein Hosseini
ALAndrew Lavigne
Andrew Lavigne
SNShanker Nesathurai
Shanker Nesathurai
Traumatic spinal cord injury (TSCI) is a significant public health challenge that has an adverse impact on functional independence, quality of life, and life expectancy. Management of people’s chronic conditions is a key aspect of contemporary medical practice. Our study was an open label, single arm, prospective pilot study to evaluate the feasibility of treating people with TSCI. The study intervention was treatment with oral selenium and vitamin E. Participants were 18 years or older and experienced a TSCI at least one year prior to enrollment. Daily doses of 50 mcg of selenium and 400 IU of vitamin E were administered. Participants had radiologic (MRI tractography) and clinical (ASIA) assessments prior to initiating treatment, and these assessments were repeated after one year of treatment. Four subjects completed the full twelve-month study. Adherence, based on pill counts, was approximately 75% in all subjects. There were no adverse events related to study medications. During the treatment period, subjects reported improvement in certain symptoms. There was no significant difference in ASIA scores before and after the intervention. Combination treatment with vitamin E and selenium has been demonstrated as safe for TSCI patients. It is possible to use DTI values to locate the epicenter of a lesion as well as gauge the extent of injury. MRI tractography may serve as a meaningful surrogate endpoint. The results of this study suggest that it is feasible to conduct a larger long-term clinical trial to evaluate the efficacy of combination treatment of TSCI.

29 September 2026 in American Journal of Physical Medicine & Rehabilitation
Verified
Journal Article
Closed access
SNShanker Nesathurai
Shanker Nesathurai
Was not provided for this article.